Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This study will examine a proposed research treatment which evaluates the addition of
oxaliplatin, a chemotherapy agent, to gemcitabine, another chemotherapy agent, and radiation
therapy for the treatment of patients with pancreatic cancer. The researchers have already
done studies using gemcitabine and radiation therapy together. They want to build on the
information they have from this previous research. The researchers believe that the
combination chemotherapy with radiation is worth investigating to treat pancreatic cancer.
They will use this study to determine what type of side effects occur with this treatment and
to assess how effective the treatment is at controlling the cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center